Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wipf

Showing results (161-170 of 430) with videos related to

Pageof 43
Sort By:
Organic Letters|November 5, 2005
Systematic assignment of the configuration of flexible natural products by spectroscopic and computational methods: the bistramide C analysisGérard Zuber, Michael-Rock Goldsmith, Tamara D Hopkins, et al.
The AAPS Journal|January 8, 2013
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic databaseLirong Wang, Chao Ma, Peter Wipf, et al.
Molecular Cancer Therapeutics|December 17, 2002
The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activityAndreas Vogt, Katharine E Pestell, Billy W Day, et al.
Chemical Biology & Drug Design|January 16, 2008
Tubulin-perturbing naphthoquinone spiroketalsRaghavan Balachandran, Tamara D Hopkins, Catherine A Thomas, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Synthesis and Optimization of Nitroxide-Based Inhibitors of Ferroptotic Cell Death in Cancer Cells and MacrophagesManwika Charaschanya, Taber S Maskrey, Matthew G LaPorte, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and BakWei Qian, Joseph Salamoun, Jingnan Wang, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubilityErin M Skoda, Joshua R Sacher, Mustafa Z Kazancioglu, et al.
Plos One|October 3, 2012
A targeted library screen reveals a new inhibitor scaffold for protein kinase DManuj Tandon, Lirong Wang, Qi Xu, et al.
Expert Opinion on Investigational Drugs|March 15, 2014
Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agentsElizabeth R Sharlow, Peter Wipf, Kelley E McQueeney, et al.
Journal of Chromatography. A|September 4, 2012
Lipophilicity screening of novel drug-like compounds and comparison to clog PDujuan Lu, Peter Chambers, Peter Wipf, et al.
Pageof 43

Showing results (161-170 of 430) with videos related to

Sort By:
Pageof 43
Organic Letters|November 5, 2005
Systematic assignment of the configuration of flexible natural products by spectroscopic and computational methods: the bistramide C analysisGérard Zuber, Michael-Rock Goldsmith, Tamara D Hopkins, et al.
The AAPS Journal|January 8, 2013
TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic databaseLirong Wang, Chao Ma, Peter Wipf, et al.
Molecular Cancer Therapeutics|December 17, 2002
The antisignaling agent SC-alpha alpha delta 9, 4-(benzyl-(2-[(2,5-diphenyloxazole-4-carbonyl)amino]ethyl)carbamoyl)- 2-decanoylaminobutyric acid, is a structurally unique phospholipid analogue with phospholipase C inhibitory activityAndreas Vogt, Katharine E Pestell, Billy W Day, et al.
Chemical Biology & Drug Design|January 16, 2008
Tubulin-perturbing naphthoquinone spiroketalsRaghavan Balachandran, Tamara D Hopkins, Catherine A Thomas, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Synthesis and Optimization of Nitroxide-Based Inhibitors of Ferroptotic Cell Death in Cancer Cells and MacrophagesManwika Charaschanya, Taber S Maskrey, Matthew G LaPorte, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
The combination of thioxodihydroquinazolinones and platinum drugs reverses platinum resistance in tumor cells by inducing mitochondrial apoptosis independent of Bax and BakWei Qian, Joseph Salamoun, Jingnan Wang, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubilityErin M Skoda, Joshua R Sacher, Mustafa Z Kazancioglu, et al.
Plos One|October 3, 2012
A targeted library screen reveals a new inhibitor scaffold for protein kinase DManuj Tandon, Lirong Wang, Qi Xu, et al.
Expert Opinion on Investigational Drugs|March 15, 2014
Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agentsElizabeth R Sharlow, Peter Wipf, Kelley E McQueeney, et al.
Journal of Chromatography. A|September 4, 2012
Lipophilicity screening of novel drug-like compounds and comparison to clog PDujuan Lu, Peter Chambers, Peter Wipf, et al.
Pageof 43